Immunologi:
Våra terapiområden

    • {%itemName%}
        {%brandMenuItems%}
    • {%itemName%} {%arrowSpan%}
        {%subBrandMenuItems%}
    • {%itemName%} {%arrowSpan%}
        {%productMenuItems%}
    • {%itemKeyName%} {%itemBadges%} {%arrowSpan%}
      {%selfProduct%}
    • {%itemName%}
      • {%countries%}
    • {%allMenuItem%}
      • {%languages%}

      • Produkter

      SKYRIZI® (risankizumab)
      RINVOQ AD® (upadacitinib)

                                                      SE-IMM-210033. Senast uppdaterad 2021-11-10